Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Pooled sgRNA screeningA customized genome-wide library divided into 48 sub-pools was generated in collaboration with the Broad Institute’s Genetic Perturbation Platform (GPP). In...
Researchers have recognized distinctive three-dimensional options known as TULIPs within the genome of posterior fossa group A (PFA) ependymoma, a difficult-to-treat mind tumor...
